Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 2)
Champions Oncology, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
15870P307
(CUSIP Number)
September 30, 2024
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| [ ] | Rule 13d-1(b) |
| [X] | Rule 13d-1(c) |
| [ ] | Rule 13d-1(d) |
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
(Continued on following pages)
CUSIP NO. 15870P307 |
13G | Page 2 of 9 Pages |
| 1 |
NAMES OF REPORTING PERSONS
WEST ELK PARTNERS, LP |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ] (b) [ ] |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED STATES OF AMERICA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
N/A |
|
| 6 |
SHARED VOTING POWER
882,581 shares of Common Stock |
||
| 7 |
SOLE DISPOSITIVE POWER
N/A |
||
| 8 |
SHARED DISPOSITIVE POWER
882,581 shares of Common Stock |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
882,581 shares of Common Stock |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.49% of the outstanding shares of Common Stock |
|
| 12 |
TYPE OF REPORTING PERSON
PN (Limited Partnership) |
CUSIP NO. 15870P307 |
13G | Page 3 of 9 Pages |
| 1 |
NAMES OF REPORTING PERSONS
WEST ELK, LLC |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ] (b) [ ] |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED STATES OF AMERICA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
N/A |
|
| 6 |
SHARED VOTING POWER
882,581 shares of Common Stock |
||
| 7 |
SOLE DISPOSITIVE POWER
N/A |
||
| 8 |
SHARED DISPOSITIVE POWER
882,581 shares of Common Stock |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
882,581 shares of Common Stock |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.49% of the outstanding shares of Common Stock |
|
| 12 |
TYPE OF REPORTING PERSON
OO (Limited Liability Company) |
C USIP NO. 15870P307 |
13G | Page 4 of 9 Pages |
| 1 |
NAMES OF REPORTING PERSONS
WEST ELK CAPITAL, LLC |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ] (b) [ ] |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
STATE OF DELAWARE, UNITED STATES OF AMERICA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
N/A |
|
| 6 |
SHARED VOTING POWER
882,581 shares of Common Stock |
||
| 7 |
SOLE DISPOSITIVE POWER
N/A |
||
| 8 |
SHARED DISPOSITIVE POWER
882,581 shares of Common Stock |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
882,581 shares of Common Stock |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.49% of the outstanding shares of Common Stock |
|
| 12 |
TYPE OF REPORTING PERSON
OO (Limited Liability Company), IA (Investment Adviser) |
CUSIP NO. 15870P307 |
13G | Page 5 of 9 Pages |
| 1 |
NAMES OF REPORTING PERSONS
Jason Joffe |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ] (b) [ ] |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
N/A |
|
| 6 |
SHARED VOTING POWER
882,581 shares of Common Stock |
||
| 7 |
SOLE DISPOSITIVE POWER
N/A |
||
| 8 |
SHARED DISPOSITIVE POWER
882,581 shares of Common Stock |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
882,581 shares of Common Stock |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.49% of the outstanding Common Stock |
|
| 12 |
TYPE OF REPORTING PERSON
IN (Individual) |
CUSIP NO. 15870P307 |
13G | Page 6 of 9 Pages |
| 1 |
NAMES OF REPORTING PERSONS
Morgan Duke |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ] (b) [ ] |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
N/A |
|
| 6 |
SHARED VOTING POWER
882,581 shares of Common Stock |
||
| 7 |
SOLE DISPOSITIVE POWER
N/A |
||
| 8 |
SHARED DISPOSITIVE POWER
882,581 shares of Common Stock |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
882,581 shares of Common Stock |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.49% of the outstanding Common Stock |
|
| 12 |
TYPE OF REPORTING PERSON
IN (Individual) |
| Item 1. | (a) | Name of Issuer: |
Champions Oncology, Inc. (the “Issuer”)
| (b) | Address of Issuer’s Principal Executive Offices: |
One University Plaza
Suite 307
Hackensack, New Jersey 07601
| Item 2. | (a) | Name of Persons Filing: |
West Elk Partners, LP
West Elk, LLC
West Elk Capital, LLC
Jason Joffe
Morgan Duke
| (b) | Address of Principal Business Office or, if None, Residence: |
For all persons filing:
1175 Peachtree Street NE
Suite 360
Atlanta, GA 30361
| (c) | Citizenship: |
West Elk Partners, LP is a Delaware limited partnership
West Elk, LLC is a Delaware limited liability company
West Elk Capital, LLC is a Delaware limited liability company
Mr. Joffe and Mr. Duke are United States citizens
| (d) | Title of Class of Securities: |
Common Stock
| (e) | CUSIP Number: |
15870P307
| Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: |
Not applicable. Filed pursuant to Rule 13d-1(c).
| Item 4. | Ownership. |
|
West Elk Partners, LP |
West Elk, LLC |
West Elk Capital, LLC |
Jason Joffe |
Morgan Duke | |||
| (a) | Amount Beneficially Owned: | 882,581 | 882,581 | 882,581 | 882,581 | 882,581 | |
| (b) | Percent of Class: | 6.49% | 6.49% | 6.49% | 6.49% | 6.49% | |
| (c) | Number of Shares to Which Reporting Person Has: | ||||||
| (i) | Sole Voting Power: | N/A | N/A | < font style="font-size: 11pt">N/A | N/A | N/A | |
| (ii) | Shared Voting Power: | 882,581 | 882,581 | 882,581 | 882,581 | 882,581 | |
| (iii) | Sole Dispositive Power: | N/A | N/A | N/A | N/A | N/A | |
| (iv) | Shared Dispositive Power: | 882,581 | 882,581 | 882,581 | 882,581 | 882,581 | |
The reported shares are the Issuer’s common stock.
All of the reported shares are owned directly by West Elk Partners, LP (“West Elk Partners”), whose general partner is West Elk, LLC (the “General Partner”) and whose investment adviser is West Elk Capital, LLC (the “Investment Adviser”). The General Partner and the Investment Adviser could each be deemed to be indirect beneficial owners of the reported shares, and could be deemed to share such beneficial ownership with West Elk Partners.
Jason Joffe and Morgan Duke are the managers of the General Partner and Investment Adviser, and could be deemed to share such indirect beneficial ownership with the General Partner, the Investment Adviser, and West Elk Partners.
| Item 5. | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
| Item 7. | Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable.
| Item 8. | Identification and Classification of Members of the Group. |
Not applicable.
| Item 9. | Notice of Dissolution of Group. |
Not applicable.
| Item 10. | Certification. |
By signing below, each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Signature
After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set forth in this Statement is true, complete and correct.
| Date: | November 14, 2024 |
WEST ELK PARTNERS, LP |
|||
| By: | West Elk, LLC, General Partner |
||
| By: | /s/ Jason Joffe |
||
| Name: | Jason Joffe |
||
| Title: | Manager |
||
| Date: | November 14, 2024 | ||
WEST ELK, LLC |
|||
| By: | /s/ Jason Joffe |
||
| Name: | Jason Joffe |
||
| Title: | Manager |
||
| Date: | November 14, 2024 | ||
WEST ELK CAPITAL, LLC |
|||
| By: | /s/ Jason Joffe |
||
| Name: | Jason Joffe |
||
| Title: | Manager |
||
| Date: | November 14, 2024 | ||
| /s/ Jason Joffe | ||
| Jason Joffe |
| Date: | November 14, 2024 |
| /s/ Morgan Duke | ||
| Morgan Duke |